Picture of Envista Holdings logo

NVST — Envista Holdings News Story

0.000.00%
us flag iconLast trade - 00:00
HealthcareBalancedLarge CapSuper Stock

Envista Q2 sales rise on segments growth

Envista Q2 sales rise on segments growth


Overview

  • US dental products maker's Q2 sales rose yr/yr, beating analyst expectations

  • Adjusted diluted EPS for Q2 rose 58% yr/yr to $0.41

  • Company raised full-year outlook for core sales growth, adjusted EBITDA, and adjusted EPS


Outlook

  • Envista raises 2026 core sales growth outlook to 3.5%-4.5% from 2%-4%

  • Company now sees 2026 adjusted EBITDA growth of 11%-14%, up from 7%-13%

  • Envista expects 2026 adjusted diluted EPS of $1.50-$1.55, up from $1.35-$1.45


Result Drivers

  • SEGMENT GROWTH - Both reporting segments delivered positive core sales growth, with Equipment & Consumables up 8.5% and Specialty Products & Technologies up 3.1%

  • OPERATIONAL IMPROVEMENTS - Margin expansion attributed to ongoing contributions from the Envista Business System


Company press release: ID:nPn3fw0qfa


Key Details

Metric

Beat/Miss

Actual

Consensus Estimate

Q2 Sales

Beat

$730.50 mln

$716.05 mln (14 Analysts)

Q2 Adjusted Net Income

$67 mln

Q2 Net Income

$54 mln

Q2 Adjusted EBITDA

$108 mln

Q2 Gross Profit

$407 mln

Q2 Operating Profit

$80.30 mln


Analyst Coverage

  • The current average analyst rating on the shares is "buy" and the breakdown of recommendations is 7 "strong buy" or "buy", 9 "hold" and no "sell" or "strong sell"

  • The average consensus recommendation for the medical equipment, supplies & distribution peer group is "buy"

  • Wall Street's median 12-month price target for Envista Holdings Corp is $31.00, about 10.9% above its August 4 closing price of $27.96

  • The stock recently traded at 18 times the next 12-month earnings vs. a P/E of 18 three months ago


Reuters Recommended Reads

  • Aug 4 - Henry Schein raises annual forecasts on strong demand for dental supplies

  • Aug 5 - Zimmer Biomet tops quarterly estimates, lifts profit forecast on strong implant demand

  • Aug 3 - Danaher names insider Julie Sawyer Montgomery as CEO


For questions concerning the data in this report, contact Estimates.Support@lseg.com. For any other questions or feedback, contact reuters.support@thomsonreuters.com.


(This story was created using Reuters automation and AI based on LSEG and company data. It was checked and edited by a Reuters journalist prior to publication.)

Recent news on Envista Holdings

See all news